Results 141 to 150 of about 32,595 (294)
Cannabis-Based Medicines ??? GW Pharmaceuticals
Drugs in R & D, 2003 GW Pharmaceuticals is undertaking a major research programme in the UK to develop and market distinct cannabis-based prescription medicines [THC:CBD, High THC, High CBD] in a range of medical conditions. The cannabis for this programme is grown in a secret location in the UK. It is expected that the product will be marketed in the US in late 2003. GW's
openaire +2 more sources
Does the total consumption model apply to cannabis use?
Addiction, EarlyView.Abstract Aims To test whether the total consumption model and its extension, the theory of collectivity, apply to adolescent cannabis use. We estimated: (1) whether the distribution of cannabis use frequency was stable over time; (2) whether changes in average cannabis use were mirrored across consumption quantiles; and (3) whether higher average use ...
Thor Norström, Håkan Leifman
wiley +1 more source
Policy formation and debate concerning the government regulation of ayurveda in Great Britain in the twenty-first century [PDF]
, 2005 Since 2000, the British House of Lords and the Government have been working towards a regulatory scheme for Complementary and Alternative medicine in Britain, a scheme that will include ayurveda.The present paper discusses these regulatory moves by the ...
Wujastyk, D
core
Addiction, EarlyView.Abstract Background and aims The impact of exposure to cannabis dispensaries on young adult cannabis use may depend on how exposures and outcomes are defined. We estimated associations of dispensary exposure with young adult cannabis use across: (a) a government‐maintained licensed dispensaries registry versus a web‐scraped list of licensed and ...
Alyssa F. Harlow +9 more
wiley +1 more source
Spartan Daily, April 18, 2019 [PDF]
, 2018 Volume 152, Issue 34https://scholarworks.sjsu.edu/spartan_daily_2019/1033/thumbnail ...
San Jose State University, School of Journalism and Mass Communications
core +2 more sources
Addiction, Volume 120, Issue 4, Page 686-687, April 2025.
Rachel Lees Thorne, Tom P. Freeman
wiley +1 more source
The prevalence of cannabidiol (CBD) use in North America and Europe: A meta‐analysis
Addiction, EarlyView.Abstract Background and aims The global cannabidiol (CBD) market has expanded in recent years. Several studies suggest CBD use, whether for medical or recreational purposes, is on the rise; however, no systematic assessments of its prevalence have been conducted so far. This meta‐analysis aimed to estimate the prevalence of CBD use in North America and
Sara Weidberg +4 more
wiley +1 more source
Expanding Production of Cannabis in Iowa [PDF]
, 2015 Following passage of Senate Bill 2360 “Medical Cannabidiol Act” in Iowa, possession of Cannabidiol Oil become legal for patients who suffered from intractable epilepsy.
DeWall, Christine +4 more
core +1 more source
Addiction, EarlyView.Abstract Background and aims Cannabis is the most widely used illicit drug worldwide and is often co‐used with tobacco, the leading cause of preventable death. Although cannabis and tobacco have distinct neurobiological actions, their associations with brain volumes are unclear.
Katherine Sawyer +16 more
wiley +1 more source
Changes over time in hallucinogen‐related emergency department visits in Ontario, Canada
Addiction, EarlyView.Abstract Background and aims Recent increasing interest in hallucinogens has underscored the critical gaps in our understanding of their adverse health effects and healthcare usage over time. The current study aimed to examine changes in emergency department (ED) visit rates involving hallucinogens, clinical outcomes of visits and the characteristics ...
Daniel T. Myran +9 more
wiley +1 more source